NDC Product
Human Prescription DrugSkyrizi NDC 0074-1050
- Generic Name
- Risankizumab-rzaa
- Dosage Form
- Injection
- Route
- Subcutaneous
- Marketing
- BLA
Active Listing
Risankizumab-rzaa 360 mg in 2.4 mL Cartridge
RxNorm 2604625 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Risankizumab-rzaa 360 mg in 2.4 mL Cartridge (RxCUI 2604625). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
